The AlphaLISA™ Human RIG-I Binding Kit is designed to select and characterize compounds that specifically bind human RIG-I protein.
Feature | Specification |
---|---|
Application | Protein Quantification |
Sample Volume | 5 µL |
The AlphaLISA™ Human RIG-I Binding Kit is designed to select and characterize compounds that specifically bind human RIG-I protein.
RIG-I (Retinoic acid-Inducible Gene I) is a cytosolic pattern recognition receptor which is known to recognize RNA pathogens in cells. This protein triggers a type 1 interferon response and participates in the innate immune system. By identifying viral dsRNA, the RIG-I protein recognizes infected cells. The N-terminus of RIG-I contacts mitochondrial antiviral signaling proteins after being triggered by a dsRNA, thereby triggering the IFN-1 signaling pathway. Recent studies have shown that RIG-I is also involved in cancer, lupus nephritis, immunoglobulin A nephropathy, Crohn’s disease, and atherosclerosis.
Application |
Protein Quantification
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Modality |
Alpha
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
RIG-I
|
Target Class |
Biomarkers
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
|
Unit Size |
500 assay points
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.